Abstract: The disclosure is a cold storage material containing: a cold storage material main agent formed from water and a melting point adjuster; and a freezing point adjuster. The melting point adjuster includes a plurality of types of inorganic salts and an organic compound. Anions of the plurality of types of inorganic salts are all chlorine, and cations of the plurality of types of inorganic salts include at least sodium. The freezing point adjuster is a salt having a functional group that is identical to a cation included in any of the plurality of types of inorganic salts, and the salt has a temperature dependence of saturated solubility in pure water that decreases by 30% or more at a water temperature from 20° C. to 0° C.

Abstract: An object is to provide a polyethylene terephthalate-based resin film that has excellent processing suitability and that particularly can effectively suppress the occurrence of cleavage in the film layer of a portion cut with a knife. Another object is to provide a polarizer, a transparent conductive film, a touch panel, and image display devices such as a liquid crystal display device and an organic EL display device, all of which use the polyethylene terephthalate-based resin film. A polyethylene terephthalate-based resin film satisfying the following (1) and (2): (1) the polyethylene terephthalate-based resin film has a retardation of 3000 to 30000 nm; and (2) the polyethylene terephthalate-based resin film has an amorphous orientation parameter of 0.330 or more as measured by an ATR-FTIR method.

Abstract: The present invention provides a preventive or therapeutic method for an inflammatory skin disease, such as psoriasis, the method comprising administering an oligopeptide as an active ingredient. More specifically, the invention provides a preventive or therapeutic method for an inflammatory skin disease, the method comprising administering an oligopeptide consisting of an amino acid sequence containing a DE loop sequence of RANKL protein and a ?-strand D sequence of RANKL protein placed adjacent to the N-terminal side of the DE loop sequence.

Abstract: The present invention provides a preventive or therapeutic agent for an inflammatory skin disease, such as psoriasis, the agent comprising an oligopeptide as an active ingredient. More specifically, the invention provides a preventive or therapeutic agent for an inflammatory skin disease, the agent comprising an oligopeptide consisting of an amino acid sequence containing a DE loop sequence of RANKL protein and a ?-strand D sequence of RANKL protein placed adjacent to the N-terminal side of the DE loop sequence.

Abstract: The present invention relates to a method for evaluating coagulability of a blood specimen obtained from a subject to whom a substance having a coagulation factor VIII-substituting activity is administered. The present invention also relates to a reagent for blood coagulation analysis, a reagent kit for blood coagulation analysis, and an apparatus for blood coagulation analysis. Furthermore, the present invention relates to an apparatus and computer program for evaluating coagulability of a blood specimen.

Abstract: The present invention relates to a method for evaluating coagulability of a blood specimen obtained from a subject to whom a substance having a coagulation factor VIII-substituting activity is administered. The present invention also relates to a reagent for blood coagulation analysis, a reagent kit for blood coagulation analysis, and an apparatus for blood coagulation analysis. Furthermore, the present invention relates to an apparatus and computer program for evaluating coagulability of a blood specimen.

Abstract: A frequency conversion method and a frequency conversion circuit which enlarge the frequency difference between the upper and lower sidebands of the output signal so as to enable the undesired sideband to be easily eliminated by a filter even in a case where the frequency of the input signal is low. First, a first excitation signal having a first excitation frequency (Fp) is modulated by an input signal (a) of a predetermined frequency (F1) to produce two sidebands and thereby generate a first intermediate signal (b). Next, a second excitation signal having a second excitation frequency (Fq) lower than the first excitation frequency (Fp) by exactly a frequency twice the frequency of the input signal (a) is modulated by the input signal (a) to produce two sidebands and thereby generate a second intermediate signal (c).